Fidelity Investments’s WisdomTree BioRevolution Fund WDNA Stock Holding History

Fidelity Investments’s Portfolio WDNA Stock Details WDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2	Closed	-$29	–	5711
2024 Q4	$29	Buy	+2	New	+$31	﹤0.01%	5296
2023 Q1	–	Sell	-1	Closed	-$17	–	5557
2022 Q4	$17	Buy	+1	New	+$18	﹤0.01%	5162

Other funds holding WDNA

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

PWMA

Pension & Wealth Management Advisors Waltham, Massachusetts $371M AUM 16.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments's WDNA Position: Q1 2025 in Review

Fidelity Investments sold out of WisdomTree BioRevolution Fund (WDNA) in Q1 2025, closing a stake of 2 shares — an estimated $29 sold.

Fidelity Investments first reported a position in WDNA in Q4 2022 and held it in 2 quarters. The position peaked at $29 in Q4 2024. 4 funds tracked by Wall St. Rank hold WDNA as of Q1 2025.

Fidelity Investments reported no remaining WisdomTree BioRevolution Fund position as of Q1 2025 after selling out during the quarter.
Fidelity Investments sold 2 WisdomTree BioRevolution Fund shares in Q1 2025, an estimated $29.
Fidelity Investments first reported a position in WisdomTree BioRevolution Fund in Q4 2022 and held it in 2 quarters.
Fidelity Investments's WisdomTree BioRevolution Fund position peaked at $29 in Q4 2024.
4 funds tracked by Wall St. Rank held WisdomTree BioRevolution Fund as of Q1 2025.

Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.